Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of oral vinorelbine plus cisplatin with induction, concurrent chemoradiotherapy, and consolidation in locally advanced unresectable non-small cell lung cancer
2009-010436-17Phase 2Active
- Sponsor
- ATHOMAV
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine and cisplatin in non-small cell lung cancer (NSCLC), sponsored by ATHOMAV. Primary endpoint: Objective response rate. Started Jul 2009; status: active.
02
Drugs
vinorelbinecisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2009-010436-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010436-17.